Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 Mar;126(3):277-81.
doi: 10.1016/j.clim.2007.11.009. Epub 2007 Dec 26.

Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly

Affiliations
Clinical Trial

Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly

Ivan K Chinn et al. Clin Immunol. 2008 Mar.

Abstract

Thymus transplantation in subjects with complete DiGeorge anomaly using postnatal allogeneic HLA-nonmatched cultured thymus tissue provides immunoreconstitution. Tolerance of the newly developed T cells toward the donor thymus has not previously been studied. Mixed lymphocyte cultures were used to test 12 thymus transplant recipients for long-term tolerance toward their thymus allografts. Two subjects tested for responses toward thymus donor peripheral blood mononuclear cells showed significantly less reactivity toward the donors compared to responses against third-party allogeneic cells. Peripheral blood mononuclear cells from 10 other subjects were less responsive toward cryopreserved donor thymic cells than toward allogeneic cells (P=0.00007). Adult control peripheral blood mononuclear cells proliferated strongly in response to the donor thymic cells. Both the subjects and controls showed similar proliferative responses against allogeneic cells and phytohemagglutinin. This study provides in vitro evidence for long-term tolerance of complete DiGeorge anomaly thymus transplantation recipients toward their HLA-nonmatched thymus grafts.

PubMed Disclaimer

Conflict of interest statement

Disclosures: None of the authors has any potential financial conflict of interest related to this manuscript.

Figures

Figure 1
Figure 1. Proliferation studies
Patient results (P) are shown compared to healthy adult controls (C). Symbols denote individual subject and corresponding control responses toward the stimuli listed at the top of each column for a given experiment; median values are shown by the horizontal bars (). DIG105 (□) had the same sample of PBMCs tested twice. DIG120 (■) had multiple control samples tested in the same assay (see text). Responses are measured by 3H-thymidine incorporation shown in counts per minute. (*) = P < 0.05, (**) = P < 0.005, (***) = P < 0.00001, NS = P ≥ 0.05.

Similar articles

Cited by

References

    1. Thomas RA, Landing BH, Wells TR. Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge Anomaly (DGA) Am J Med Genetics Suppl. 1987;3:43–66. - PubMed
    1. DiGeorge AM. Discussion of Cooper MD, Peterson RDA, Good RA. A new concept of cellular basis of immunity. J Pediatrics. 1965;67:907.
    1. Conley ME, Beckwith JB, Mancer JFK, Tenckhoff L. The Spectrum of the DiGeorge Syndrome. J Pediatrics. 1979;94:883–890. - PubMed
    1. Müller W, Peter HH, Wilken M, Juppner H, Kallfelz HC, Krohn HP, Miller K, Rieger CH. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatrics. 1988;147:496–502. - PubMed
    1. Hong R. The DiGeorge Anomaly. Immunodefic Rev. 1991;3:1–14. - PubMed

Publication types